Scientists discover structure of protein essential for quality control, nerve function

(Press-News.org) LA JOLLA, CA – January 14, 2013 – Using an innovative approach, scientists at The Scripps Research Institute (TSRI) have determined the structure of Ltn1, a recently discovered "quality-control" protein that is found in the cells of all plants, fungi and animals.

Ltn1 appears to be essential for keeping cells' protein-making machinery working smoothly. It may also be relevant to human neurodegenerative diseases, for an Ltn1 mutation in mice leads to a motor-neuron disease resembling amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease).

"To better understand Ltn1's mechanism of action, we needed to solve its structure, and that's what we've done here," said TSRI Associate Professor Claudio Joazeiro.

"In addition, this project has brought us a set of structural analysis techniques that we can apply to other exciting problems in biology," said TSRI Professor Bridget Carragher.

Joazeiro and Carragher, along with Clint Potter, also a TSRI professor, are senior authors of the new report, which appears in the online Early Edition of the Proceedings of the National Academy of Sciences the week of January 14, 2013.

Links to Neurodegenerative Disease

Ltn1 first turned up on biologists' radar screens several years ago when a joint Novartis-Phenomix research team noted that mice with an unknown gene mutation were born normal but suffered from progressive paralysis. The scientists dubbed the animals lister mice, because they listed to one side as they walked. Collaborating with Joazeiro, the Novartis team reported in a 2009 paper that the mutated gene normally codes for a type of enzyme known as an E3 ubiquitin ligase, and that the mouse phenotype was due to a neurodegenerative syndrome resembling ALS.

In a study published in the journal Nature the following year, Joazeiro and his postdoctoral research associate Mario H. Bengtson found that the enzyme serves as a crucial quality-control manager for the cellular protein-making factories called ribosomes. Occasionally a ribosome receives miscoded genetic instructions and produces certain types of abnormal proteins, known as "nonstop proteins"— jamming the ribosomal machinery like a wrinkled sheet of paper in an office printer. Bengtson and Joazeiro found that Ltn1 fixes jammed ribosomes by tagging nonstop proteins with ubiquitin molecules, thereby marking them for quick destruction by roving cellular garbage-disposers called proteasomes.

"The question for us then was, "How does Ltn1 do this?' " said Joazeiro.

Pushing the Boundaries of Electron Microscopy

To help find out, he began a collaboration with Carragher and Potter, who run the National Resource for Automated Molecular Microscopy (NRAMM), an advanced electron microscope facility at TSRI that is funded by the National Institutes of Health's National Center for Research Resources.

Ltn1 was deemed too large for its structure to be determined by current nuclear magnetic resonance (NMR) technology, and, as the scientists know now, too flexible to allow the highly regular crystalline packing needed by X-ray crystallographers. "It's a very floppy molecule, so it would be hard to crystallize," said Potter.

Advanced electron microscopy offered a way, however. Dmitry Lyumkis, a graduate student in the NRAMM laboratory and first author of the study, took high-resolution images of yeast Ltn1 with an electron microscope. He then used sophisticated image and data processing software to align and average individual images. The technique eliminates much of the random "noise" that obscures single images and produces a sharp 3D picture of the protein.

No one has ever used electron microscopy to distinguish so many—more than 20—conformations of such a small protein. "Usually electron microscopists determine no more than two or three conformational states, and they work with protein complexes whose size is in the megadalton range, but Ltn1 is only 180 kilodaltons, an order of magnitude smaller," Lyumkis said.

An Unusually Flexible Structure

The analysis revealed that Ltn1 has an elongated, double-jointed and extraordinarily flexible structure with two working ends—the N-terminus and C-terminus. "We anticipate that the N-terminus is responsible for association with the ribosome and know that the C-terminus is responsible for the ubiquitylation of nonstop proteins," said Lyumkis. "We suspect that the high flexibility of this structure is needed for it to work on the variety of nonstop proteins that can get stuck in ribosomes."

One of the next steps for the team is to evaluate Ltn1's individual segments, which appear to be more rigid, using X-ray crystallography, in order to develop a piece-by-piece atomic-resolution model of the enzyme. Another is to determine the structure of Ltn1 when it is attached to a ribosome and operating on a nonstop protein. Joazeiro notes that a typical yeast cell has nearly 200,000 ribosomes but requires only 200 Ltn1 copies for adequate quality control under normal growth conditions. "Somehow this enzyme can efficiently sense which ribosomes are jammed, and we expect that by solving the joint structure of Ltn1 and a ribosome, we'll be able to understand how it does this," he says.

Lyumkis, Carragher, Potter and their colleagues at NRAMM also plan to use a similar electron microscopy-based approach to find the structures of other important proteins with highly variable "heterogeneous" conformations. "Heterogeneity has been a big challenge," said Potter, "and being able to collect this large dataset and do all of this data processing successfully has been a critical breakthrough."



INFORMATION:

Other contributors to the paper, "Single-particle EM reveals extensive conformational variability of the Ltn1 E3 ligase," were Selom K. Doamekpor and Christopher D. Lima at the Sloan–Kettering Institute; Tasha B. Toro and Matthew D. Petroski of the Sanford-Burnham Medical Research Institute; and Mario H. Bengtson and Joong-Won Lee of TSRI.

The study was supported by grants from the National Center for Research Resources (RR017573); the National Institute of General Medical Sciences (GM103310); the National Institutes of Health (R01 GM083060, R01 NS075719, GM061906); and the American Cancer Society (RSG-11-224-01-DMC, RSG-08-298-01-TBE).